Skip to main content
FDA Shortage Check

Is Vidaza (Azacitidine Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Vidaza: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Discontinuation of the manufacture of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Armas Pharmaceuticals Inc, Jun 8, 2026
DRUG
Vidaza
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Dec 18, 2020
LAST FDA UPDATE
Oct 20, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 9 presentations: 4 unavailable · 1 limited · 4 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Azacitidine Injection. 9 presentations from 9 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Armas Pharmaceuticals Inc1 presentation · 1 limited

Contact (FDA's listing): 732-637-1971

  • 100 mg

    Azacitidine, Injection, 100 mg (NDC 72485-201-01)

    Estimated recovery: TBD

    NDC 72485-201-01Revised

    Limited Availability

Eugia US LLC1 presentation · 1 unavailable

Contact (FDA's listing): 888-238-7880

  • 100 mg/4 mL

    Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)

    On backorder. Recovery: TBD. Check wholesalers for inventory

    NDC 55150-393-01Reverified

    Unavailable

Fresenius Kabi USA, LLC1 presentation · 1 unavailable

Contact (FDA's listing): 1-888-386-1300

  • 100 mg/30 mL

    Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)

    Discontinuation of the manufacture of the drug

    NDC 63323-771-39Reverified

    Unavailable

Hikma Pharmaceuticals USA, Inc.1 presentation · 1 unavailable

Contact (FDA's listing): 1-800-631-2174

  • 100 mg/ Vial

    Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)

    Product temporarily on backorder. Additional lots will be available the end of October 2026.

    NDC 0143-9606-01Revised

    Unavailable

Teva Pharmaceuticals USA, Inc.1 presentation · 1 unavailable

Contact (FDA's listing): 800-545-8800

  • 100 mg

    Azacitidine, Injection, 100 mg (NDC 68001-313-56)

    Estimated recovery: TBD

    NDC 68001-313-56Reverified

    Unavailable

Accord Healthcare Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 866-941-7875, option 2

  • 100 mg

    Azacitidine, Injection, 100 mg (NDC 16729-306-10)

    NDC 16729-306-10Reverified

    Available

Bristol Myers Squibb Co.1 presentation · 1 available or not stated

Contact (FDA's listing): 1-888-423-5436

  • 100 mg

    Vidaza, Injection, 100 mg (NDC 59572-102-01)

    NDC 59572-102-01Reverified

    Available

Dr. Reddy's Laboratories, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 866-732-3952

  • 100 mg

    Azacitidine, Injection, 100 mg (NDC 43598-305-62)

    Available to existing customers

    NDC 43598-305-62Reverified

    Available

Meitheal Pharmaceuticals, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 844-824-8426

  • 100 mg/30 mL

    Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)

    NDC 71288-115-30Reverified

    Available

What the manufacturers told FDA

  • Armas Pharmaceuticals Inc · ‘Estimated recovery: TBD’ · updated Jun 2026
  • Eugia US LLC · ‘On backorder. Recovery: TBD. Check wholesalers for inventory’ · updated Oct 2026
  • Teva Pharmaceuticals USA, Inc. · ‘Estimated recovery: TBD’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Discontinuation of the manufacture of the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Vidaza in shortage?
Yes. As of Oct 24, 2026, FDA lists Azacitidine Injection as currently in shortage: 9 presentations, 4 unavailable and 1 limited.
When will the Vidaza shortage end?
FDA gives no end date. 2 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Vidaza?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.